A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction.
about
Efficacy of psychostimulant drugs for amphetamine abuse or dependencePharmacotherapy of amphetamine-type stimulant dependence: an updateAgonist replacement for stimulant dependence: a review of clinical researchAgonist Medications for the Treatment of Cocaine Use DisorderPharmacotherapeutic agents in the treatment of methamphetamine dependence.Pharmacological treatments for methamphetamine addiction: current status and future directions.Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users.Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literatureTreatments for methamphetamine abuse: a literature review for the clinician.Breakingtheice: a protocol for a randomised controlled trial of an internet-based intervention addressing amphetamine-type stimulant use.Wake-promoting pharmacotherapy for psychiatric disorders.Methamphetamine self-administration in humans during D-amphetamine maintenance.Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.Reduction of the reinforcing effectiveness of cocaine by continuous D-amphetamine treatment in rats: importance of active self-administration during treatment periodImpact of prospectively determined A118G polymorphism on treatment response to injectable naltrexone among methamphetamine-dependent patients: an open-label, pilot study.Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.Psychostimulant addiction treatment.Effects of 7-day continuous D-amphetamine, methylphenidate, and cocaine treatment on choice between methamphetamine and food in male rhesus monkeys.Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysisStudy protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependenceFactors Associated With Adherence to Methylphenidate Treatment in Adult Patients With Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders.Amphetamines, the pregnant woman and her children: a review.Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder.Acute buspirone dosing enhances abuse-related subjective effects of oral methamphetamine.The neurobiological mechanisms of physical exercise in methamphetamine addiction.Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.Commentary on Konstenius et al. (2014): on medication development for stimulant addiction.
P2860
Q24198261-95FC76DB-E984-4EED-98B2-031567AB42D2Q26991936-C9318A3B-555F-45F0-BBBC-5102FDEF5B59Q27014854-8142519D-A8AB-4A6D-8E75-DFF53885D2D7Q28087404-BE3A078A-2BA8-4278-81CA-D6A9C9C3E9C4Q30235058-A0AAD008-55F4-438B-9E50-07A6C654A307Q30240173-8A98461C-A576-4849-BB71-C394AC7990DEQ34021980-615B26AF-2BF0-44B0-A688-459E184D9BBAQ34149087-E4A38B9F-DE6C-4AC6-A534-320C87E91F51Q34181746-48DC919E-EA80-4193-AE0B-F85E5BFD4F25Q34233794-B3F233FF-B3EE-4A2B-96F7-F3778417DCFDQ34316721-CE575A7F-C6C3-495F-A045-0A30CB738226Q34443394-E24F3745-D4CA-4D0D-8CAF-063F34928F93Q34550457-6F635FFA-7F7C-4CE8-9935-7669361BB92EQ34673305-A52329CF-2D80-4C16-9A51-B443224F9103Q34981228-28E33401-6CB5-44A4-966F-05CDBC70C197Q35082614-A1166DD2-6514-4552-B7BD-BCFDC15272A5Q35220474-01C6C1C0-DCEC-4E2D-AB17-1E9A63BC6245Q35576598-B062A5CD-0466-440E-B817-764275DB65F4Q35915231-7177267F-DF2C-42B8-A133-B6D0803A8FA6Q36090475-DD16FA1B-D7CE-406A-AF0B-B75C1CA116B7Q36192104-79827C4D-1E1C-40DC-B6C2-C5E24FDA0DA2Q36209156-038C7470-334B-4F6F-A070-38C5B82601ECQ36813731-0B5BA8F8-EF9C-4222-BF9C-DE3C58D6A6F7Q38015058-76A4DDCF-BF50-4812-9EF4-FF8C7E7971E6Q39034288-1F041C7D-A224-460A-9E01-539CBD7E59A1Q42841373-02260043-6FF3-4461-B30E-2080FCEE9FF9Q47268750-5E2ED8FD-CFA5-43AF-9FC7-A92E0169BAE3Q52302064-F8011DA4-CFAF-41F9-9953-7BB470715978Q52304091-8FCE1993-5B8D-4051-862B-15311D5EC8B7
P2860
A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A randomized, placebo-controll ...... of methamphetamine addiction.
@ast
A randomized, placebo-controll ...... of methamphetamine addiction.
@en
A randomized, placebo-controll ...... of methamphetamine addiction.
@nl
type
label
A randomized, placebo-controll ...... of methamphetamine addiction.
@ast
A randomized, placebo-controll ...... of methamphetamine addiction.
@en
A randomized, placebo-controll ...... of methamphetamine addiction.
@nl
prefLabel
A randomized, placebo-controll ...... of methamphetamine addiction.
@ast
A randomized, placebo-controll ...... of methamphetamine addiction.
@en
A randomized, placebo-controll ...... of methamphetamine addiction.
@nl
P2093
P2860
P356
P1476
A randomized, placebo-controll ...... of methamphetamine addiction.
@en
P2093
C Y A Chen
G P Galloway
J D Siegrist
J Mendelson
P2860
P304
P356
10.1038/CLPT.2010.307
P407
P577
2010-12-22T00:00:00Z